funding_articleMay 20, 2026Confidence: high
Ritivel | Y Combinator
Winter 2026 (W26) batch. AI-native regulatory platform drafting life-sciences submissions in minutes.
Affected score: yesObserved: May 20, 2026Round: Pre-Seed
raisedpre-seed
R
Ritivel
Pre-SeedMarket data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Beta
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Investor read
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:12 PM
Beta
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
What they do
Ritivel Regulatory document automation for pharma.
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).
Quick read
- •Ritivel Regulatory document automation for pharma.
- •Reported angle: Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
- •Indexed activity snapshot: 1 funding‑related row(s), 0 hiring‑related, 0 GitHub‑tagged, 5 product/news‑style — scoring reflects corpus coverage only.
Stage
Seed (YC)
Evidence summary
Verified facts
- •Ritivel Regulatory document automation for pharma.
- •Reported angle: Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
- •Indexed activity snapshot: 1 funding‑related row(s), 0 hiring‑related, 0 GitHub‑tagged, 5 product/news‑style — scoring reflects corpus coverage only.
Recent movers
- •May 11, 2026 · Blog / news — Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
- •May 11, 2026 · Blog / news — JPM26: Where Pharma & Biotech Are Headed — By the Numbers
- •May 11, 2026 · Blog / news — The EMA-FDA Guiding Principles for AI in Drug Development: A Reference Guide
+3 more in Recent movement below
- •May 11, 2026 · Blog / news — Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
- •May 11, 2026 · Blog / news — JPM26: Where Pharma & Biotech Are Headed — By the Numbers
- •May 11, 2026 · Blog / news — The EMA-FDA Guiding Principles for AI in Drug Development: A Reference Guide
- •May 11, 2026 · Blog / news — Clinical Trial Success Rates: An Analysis of 450,000+ Trials
- •May 20, 2026 · ycombinator.com — Ritivel | Y Combinator
- •May 20, 2026 · ycombinator.com — Launch YC: Ritivel
- •Y Combinator
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).
Hiring
No hiring/careers evidence indexed (Low).
GitHub
No GitHub‑linked evidence indexed (Low).
Product / news
5 product/news‑styled row(s); headline risk without filings (High).
Traffic / social
No traffic/social evidence indexed (Low).
Funding & hiring signals
Open roles (indexed)
No open roles indexed yet.
Failed or blocked links
- public_page:_pressnot_foundLast checked Mon, May 11, 04:40 AM
HTTP 404
- public_page:_newsnot_foundLast checked Mon, May 11, 04:40 AM
HTTP 404
- public_page:_jobsnot_foundLast checked Mon, May 11, 04:40 AM
HTTP 404
- public_page:_companynot_foundLast checked Mon, May 11, 04:40 AM
HTTP 404
- public_page:_careersnot_foundLast checked Mon, May 11, 04:40 AM
HTTP 404
DealFlow growth score
47.0Moderate public activity signal
7D-28%
30D+4%
Needs Review
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
Source health
- public_market_enrichmentokLast checked Mon, May 11, 04:40 AM
- public_page:_blog_retrieval-benchmark-confusable-drug-namesokLast checked Mon, May 11, 04:40 AM
- public_page:_blog_jpm26-pharma-biotech-industry-analysisokLast checked Mon, May 11, 04:40 AM
- public_page:_blog_hidden-cost-ai-hallucinations-critical-documentsokLast checked Mon, May 11, 04:40 AM
- public_page:_blog_ema-fda-guiding-principles-ai-drug-developmentokLast checked Mon, May 11, 04:40 AM
- public_page:_blog_clinical-trial-success-rates-21st-centuryokLast checked Mon, May 11, 04:40 AM
- public_page:_blogokLast checked Mon, May 11, 04:40 AM
- public_page:_aboutokLast checked Mon, May 11, 04:40 AM
- public_page:_okLast checked Mon, May 11, 04:40 AM
- public_page:homeokLast checked Mon, May 11, 04:40 AM
DealFlow score momentum
477D -2830D +4
100500
More runs will build history.
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
Signal breakdown
Latest momentum signal per category. Expand a card to inspect raw payloads.
Public source summary
- Total evidence rows
- 8
- Latest evidence
- Wed, May 20, 06:12 PM
Source types found
about_pageblogcompany_sitefunding_articlepress
Strongest / recent news-style rows
Ritivel | Y Combinator
Wed, May 20, 06:12 PM · confidence 88%high quality
https://www.ycombinator.com/companies/ritivelAbout Ritivel
About / company · Mon, May 11, 04:39 AM · confidence 90%high quality
https://www.ritivel.com/aboutLaunch YC: Ritivel
Wed, May 20, 06:12 PM · confidence 85%medium quality
https://www.ycombinator.com/launches/PJn-ritivel-ai-native-platform-for-regulatory-document-submission
Public signal timeline
Newest first · 8 event(s)
1
Wed, May 20, 06:12 PM · funding_article · 88% · verified_publichigh quality
Source ↗Ritivel | Y Combinator
Winter 2026 (W26) batch. AI-native regulatory platform drafting life-sciences submissions in minutes.
2
Wed, May 20, 06:12 PM · company_site · 85% · verified_publichigh quality
Source ↗Ritivel
Regulatory document automation for pharma.
3
Mon, May 11, 04:39 AM · blog · 90% · publichigh quality
Source ↗Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
Source: Blog / news
Standard retrieval fails on 50% of queries involving similar drug names. Context-enriched retrieval cuts that failure rate by 80%. Here's what we learned building a benchmark to test it.
4
Mon, May 11, 04:39 AM · blog · 90% · publichigh quality
Source ↗JPM26: Where Pharma & Biotech Are Headed — By the Numbers
Source: Blog / news
A data-driven analysis of the 2026 J.P. Morgan Healthcare Conference. $116B in M&A, $180B at risk from patent cliffs, and the trends reshaping drug development.
5
Mon, May 11, 04:39 AM · blog · 90% · publichigh quality
Source ↗The EMA-FDA Guiding Principles for AI in Drug Development: A Reference Guide
Source: Blog / news
A detailed breakdown of the 10 joint EMA-FDA principles for AI in drug development. Includes definitions of key technical terms like GxP, data drift, and model validation.
6
Mon, May 11, 04:39 AM · blog · 90% · publichigh quality
Source ↗Clinical Trial Success Rates: An Analysis of 450,000+ Trials
Source: Blog / news
Examining the latest published data on clinical trial success rates by phase, therapeutic area, and development timeline. What the numbers tell us about where drugs succeed and fail.
7
Mon, May 11, 04:39 AM · about_page · 90% · publichigh quality
Source ↗About Ritivel
Source: About / company
Ritivel is building the AI-native regulatory platform for life sciences. Backed by Y Combinator, built by experts from Microsoft and Kearney.
8
Wed, May 20, 06:12 PM · press · 85% · verified_publicmedium quality
Source ↗Launch YC: Ritivel
Draft clinical study reports in minutes.
Official / company site
1 row(s)
company_site·Wed, May 20, 06:12 PM·Confidence 85%high qualityverified_public
Ritivel
Regulatory document automation for pharma.
https://www.ritivel.com/News
2 row(s)
about_page·Mon, May 11, 04:39 AM·Confidence 90%high qualitypublic
About Ritivel
Source name: About / company
Ritivel is building the AI-native regulatory platform for life sciences. Backed by Y Combinator, built by experts from Microsoft and Kearney.
https://www.ritivel.com/aboutpress·Wed, May 20, 06:12 PM·Confidence 85%medium qualityverified_public
Launch YC: Ritivel
Draft clinical study reports in minutes.
https://www.ycombinator.com/launches/PJn-ritivel-ai-native-platform-for-regulatory-document-submissionFunding / news
1 row(s)
funding_article·Wed, May 20, 06:12 PM·Confidence 88%high qualityverified_public
Ritivel | Y Combinator
Winter 2026 (W26) batch. AI-native regulatory platform drafting life-sciences submissions in minutes.
https://www.ycombinator.com/companies/ritivelBlog
4 row(s)
blog·Mon, May 11, 04:39 AM·Confidence 90%high qualitypublic
Why Drug Name Confusion Breaks RAG Systems — And How to Fix It
Source name: Blog / news
Standard retrieval fails on 50% of queries involving similar drug names. Context-enriched retrieval cuts that failure rate by 80%. Here's what we learned building a benchmark to test it.
https://www.ritivel.com/blog/retrieval-benchmark-confusable-drug-namesblog·Mon, May 11, 04:39 AM·Confidence 90%high qualitypublic
JPM26: Where Pharma & Biotech Are Headed — By the Numbers
Source name: Blog / news
A data-driven analysis of the 2026 J.P. Morgan Healthcare Conference. $116B in M&A, $180B at risk from patent cliffs, and the trends reshaping drug development.
https://www.ritivel.com/blog/jpm26-pharma-biotech-industry-analysisblog·Mon, May 11, 04:39 AM·Confidence 90%high qualitypublic
The EMA-FDA Guiding Principles for AI in Drug Development: A Reference Guide
Source name: Blog / news
A detailed breakdown of the 10 joint EMA-FDA principles for AI in drug development. Includes definitions of key technical terms like GxP, data drift, and model validation.
https://www.ritivel.com/blog/ema-fda-guiding-principles-ai-drug-developmentblog·Mon, May 11, 04:39 AM·Confidence 90%high qualitypublic
Clinical Trial Success Rates: An Analysis of 450,000+ Trials
Source name: Blog / news
Examining the latest published data on clinical trial success rates by phase, therapeutic area, and development timeline. What the numbers tell us about where drugs succeed and fail.
https://www.ritivel.com/blog/clinical-trial-success-rates-21st-centuryPrivate workspace
Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.